Cargando…

Should Lymph Nodes Be Retrieved in Patients with Intrahepatic Cholangiocarcinoma? A Collaborative Korea–Japan Study

SIMPLE SUMMARY: Intrahepatic cholangiocarcinoma (IHCC) is the second most common primary hepatic malignant tumor after hepatocellular carcinoma (HCC). The prevalence of lymph node metastases (LNM) detected at surgery for IHCC has been reported as 25–50%, and lymph node metastasis is known to be sign...

Descripción completa

Detalles Bibliográficos
Autores principales: Kang, Chang Moo, Suh, Kyung-Suk, Yi, Nam-Joon, Hong, Tae Ho, Park, Sang Jae, Ahn, Keun Soo, Hayashi, Hiroki, Choi, Sae Byeol, Jeong, Chi-Young, Takahara, Takeshi, Shiozaki, Shigehiro, Roh, Young Hoon, Yu, Hee Chul, Fukumoto, Takumi, Matsuyama, Ryusei, Naoki, Uyama, Hashida, Kazuki, Seo, Hyung Il, Okabayashi, Takehiro, Kitajima, Tomoo, SATOI, Sohei, Nagano, Hiroaki, Kim, Hongbeom, Taira, Kaoru, Kubo, Shoji, Choi, Dong Wook
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7865580/
https://www.ncbi.nlm.nih.gov/pubmed/33503932
http://dx.doi.org/10.3390/cancers13030445
_version_ 1783647879659782144
author Kang, Chang Moo
Suh, Kyung-Suk
Yi, Nam-Joon
Hong, Tae Ho
Park, Sang Jae
Ahn, Keun Soo
Hayashi, Hiroki
Choi, Sae Byeol
Jeong, Chi-Young
Takahara, Takeshi
Shiozaki, Shigehiro
Roh, Young Hoon
Yu, Hee Chul
Fukumoto, Takumi
Matsuyama, Ryusei
Naoki, Uyama
Hashida, Kazuki
Seo, Hyung Il
Okabayashi, Takehiro
Kitajima, Tomoo
SATOI, Sohei
Nagano, Hiroaki
Kim, Hongbeom
Taira, Kaoru
Kubo, Shoji
Choi, Dong Wook
author_facet Kang, Chang Moo
Suh, Kyung-Suk
Yi, Nam-Joon
Hong, Tae Ho
Park, Sang Jae
Ahn, Keun Soo
Hayashi, Hiroki
Choi, Sae Byeol
Jeong, Chi-Young
Takahara, Takeshi
Shiozaki, Shigehiro
Roh, Young Hoon
Yu, Hee Chul
Fukumoto, Takumi
Matsuyama, Ryusei
Naoki, Uyama
Hashida, Kazuki
Seo, Hyung Il
Okabayashi, Takehiro
Kitajima, Tomoo
SATOI, Sohei
Nagano, Hiroaki
Kim, Hongbeom
Taira, Kaoru
Kubo, Shoji
Choi, Dong Wook
author_sort Kang, Chang Moo
collection PubMed
description SIMPLE SUMMARY: Intrahepatic cholangiocarcinoma (IHCC) is the second most common primary hepatic malignant tumor after hepatocellular carcinoma (HCC). The prevalence of lymph node metastases (LNM) detected at surgery for IHCC has been reported as 25–50%, and lymph node metastasis is known to be significantly associated with poor survival outcomes. However, the oncologic value of lymph node dissection in resected IHCC is still controversial. According to the present Korea–Japan international collaborative study, it was found that surgical retrieval of more than four lymph nodes (≥4 LNs) could improve survival outcome in resected IHCC with LNM. Based on preoperatively detectable parameters, a nomogram was established to predict LNM to suggest tailored intraoperative LN management in patients with IHCC. Further prospective research is needed to validate the present surgical strategy in resected IHCC. ABSTRACT: Background: This study was performed to investigate the oncologic role of lymph node (LN) management and to propose a surgical strategy for treating intrahepatic cholangiocarcinoma (IHCC). Methods: The medical records of patients with resected IHCC were retrospectively reviewed from multiple institutions in Korea and Japan. Short-term and long-term oncologic outcomes were analyzed according to lymph node metastasis (LNM). A nomogram to predict LNM in treating IHCC was established to propose a surgical strategy for managing IHCC. Results: A total of 1138 patients were enrolled. Of these, 413 patients underwent LN management and 725 did not. A total of 293 patients were found to have LNM. The No. 12 lymph node (36%) was the most frequent metastatic node, and the No. 8 lymph node (21%) was the second most common. LNM showed adverse long-term oncologic impact in patients with resected IHCC (14 months, 95% CI (11.4–16.6) vs. 74 months, 95% CI (57.2–90.8), p < 0.001), and the number of LNM (0, 1–3, 4≤) was also significantly related to negative oncologic impacts in patients with resected IHCC (74 months, 95% CI (57.2–90.8) vs. 19 months, 95% CI (14.4–23.6) vs. 11 months, 95% CI (8.1–13.8)), p < 0.001). Surgical retrieval of more than four (≥4) LNs could improve the survival outcome in resected IHCC with LNM (13 months, 95% CI (10.4–15.6)) vs. 30 months, 95% CI (13.1–46.9), p = 0.045). Based on preoperatively detectable parameters, a nomogram was established to predict LNM according to the tumor location. The AUC was 0.748 (95% CI: 0.706–0.788), and the Hosmer and Lemeshow goodness of fit test showed p = 0.4904. Conclusion: Case-specific surgical retrieval of more than four LNs is required in patients highly suspected to have LNM, based on a preoperative detectable parameter-based nomogram. Further prospective research is needed to validate the present surgical strategy in resected IHCC.
format Online
Article
Text
id pubmed-7865580
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-78655802021-02-07 Should Lymph Nodes Be Retrieved in Patients with Intrahepatic Cholangiocarcinoma? A Collaborative Korea–Japan Study Kang, Chang Moo Suh, Kyung-Suk Yi, Nam-Joon Hong, Tae Ho Park, Sang Jae Ahn, Keun Soo Hayashi, Hiroki Choi, Sae Byeol Jeong, Chi-Young Takahara, Takeshi Shiozaki, Shigehiro Roh, Young Hoon Yu, Hee Chul Fukumoto, Takumi Matsuyama, Ryusei Naoki, Uyama Hashida, Kazuki Seo, Hyung Il Okabayashi, Takehiro Kitajima, Tomoo SATOI, Sohei Nagano, Hiroaki Kim, Hongbeom Taira, Kaoru Kubo, Shoji Choi, Dong Wook Cancers (Basel) Article SIMPLE SUMMARY: Intrahepatic cholangiocarcinoma (IHCC) is the second most common primary hepatic malignant tumor after hepatocellular carcinoma (HCC). The prevalence of lymph node metastases (LNM) detected at surgery for IHCC has been reported as 25–50%, and lymph node metastasis is known to be significantly associated with poor survival outcomes. However, the oncologic value of lymph node dissection in resected IHCC is still controversial. According to the present Korea–Japan international collaborative study, it was found that surgical retrieval of more than four lymph nodes (≥4 LNs) could improve survival outcome in resected IHCC with LNM. Based on preoperatively detectable parameters, a nomogram was established to predict LNM to suggest tailored intraoperative LN management in patients with IHCC. Further prospective research is needed to validate the present surgical strategy in resected IHCC. ABSTRACT: Background: This study was performed to investigate the oncologic role of lymph node (LN) management and to propose a surgical strategy for treating intrahepatic cholangiocarcinoma (IHCC). Methods: The medical records of patients with resected IHCC were retrospectively reviewed from multiple institutions in Korea and Japan. Short-term and long-term oncologic outcomes were analyzed according to lymph node metastasis (LNM). A nomogram to predict LNM in treating IHCC was established to propose a surgical strategy for managing IHCC. Results: A total of 1138 patients were enrolled. Of these, 413 patients underwent LN management and 725 did not. A total of 293 patients were found to have LNM. The No. 12 lymph node (36%) was the most frequent metastatic node, and the No. 8 lymph node (21%) was the second most common. LNM showed adverse long-term oncologic impact in patients with resected IHCC (14 months, 95% CI (11.4–16.6) vs. 74 months, 95% CI (57.2–90.8), p < 0.001), and the number of LNM (0, 1–3, 4≤) was also significantly related to negative oncologic impacts in patients with resected IHCC (74 months, 95% CI (57.2–90.8) vs. 19 months, 95% CI (14.4–23.6) vs. 11 months, 95% CI (8.1–13.8)), p < 0.001). Surgical retrieval of more than four (≥4) LNs could improve the survival outcome in resected IHCC with LNM (13 months, 95% CI (10.4–15.6)) vs. 30 months, 95% CI (13.1–46.9), p = 0.045). Based on preoperatively detectable parameters, a nomogram was established to predict LNM according to the tumor location. The AUC was 0.748 (95% CI: 0.706–0.788), and the Hosmer and Lemeshow goodness of fit test showed p = 0.4904. Conclusion: Case-specific surgical retrieval of more than four LNs is required in patients highly suspected to have LNM, based on a preoperative detectable parameter-based nomogram. Further prospective research is needed to validate the present surgical strategy in resected IHCC. MDPI 2021-01-25 /pmc/articles/PMC7865580/ /pubmed/33503932 http://dx.doi.org/10.3390/cancers13030445 Text en © 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Kang, Chang Moo
Suh, Kyung-Suk
Yi, Nam-Joon
Hong, Tae Ho
Park, Sang Jae
Ahn, Keun Soo
Hayashi, Hiroki
Choi, Sae Byeol
Jeong, Chi-Young
Takahara, Takeshi
Shiozaki, Shigehiro
Roh, Young Hoon
Yu, Hee Chul
Fukumoto, Takumi
Matsuyama, Ryusei
Naoki, Uyama
Hashida, Kazuki
Seo, Hyung Il
Okabayashi, Takehiro
Kitajima, Tomoo
SATOI, Sohei
Nagano, Hiroaki
Kim, Hongbeom
Taira, Kaoru
Kubo, Shoji
Choi, Dong Wook
Should Lymph Nodes Be Retrieved in Patients with Intrahepatic Cholangiocarcinoma? A Collaborative Korea–Japan Study
title Should Lymph Nodes Be Retrieved in Patients with Intrahepatic Cholangiocarcinoma? A Collaborative Korea–Japan Study
title_full Should Lymph Nodes Be Retrieved in Patients with Intrahepatic Cholangiocarcinoma? A Collaborative Korea–Japan Study
title_fullStr Should Lymph Nodes Be Retrieved in Patients with Intrahepatic Cholangiocarcinoma? A Collaborative Korea–Japan Study
title_full_unstemmed Should Lymph Nodes Be Retrieved in Patients with Intrahepatic Cholangiocarcinoma? A Collaborative Korea–Japan Study
title_short Should Lymph Nodes Be Retrieved in Patients with Intrahepatic Cholangiocarcinoma? A Collaborative Korea–Japan Study
title_sort should lymph nodes be retrieved in patients with intrahepatic cholangiocarcinoma? a collaborative korea–japan study
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7865580/
https://www.ncbi.nlm.nih.gov/pubmed/33503932
http://dx.doi.org/10.3390/cancers13030445
work_keys_str_mv AT kangchangmoo shouldlymphnodesberetrievedinpatientswithintrahepaticcholangiocarcinomaacollaborativekoreajapanstudy
AT suhkyungsuk shouldlymphnodesberetrievedinpatientswithintrahepaticcholangiocarcinomaacollaborativekoreajapanstudy
AT yinamjoon shouldlymphnodesberetrievedinpatientswithintrahepaticcholangiocarcinomaacollaborativekoreajapanstudy
AT hongtaeho shouldlymphnodesberetrievedinpatientswithintrahepaticcholangiocarcinomaacollaborativekoreajapanstudy
AT parksangjae shouldlymphnodesberetrievedinpatientswithintrahepaticcholangiocarcinomaacollaborativekoreajapanstudy
AT ahnkeunsoo shouldlymphnodesberetrievedinpatientswithintrahepaticcholangiocarcinomaacollaborativekoreajapanstudy
AT hayashihiroki shouldlymphnodesberetrievedinpatientswithintrahepaticcholangiocarcinomaacollaborativekoreajapanstudy
AT choisaebyeol shouldlymphnodesberetrievedinpatientswithintrahepaticcholangiocarcinomaacollaborativekoreajapanstudy
AT jeongchiyoung shouldlymphnodesberetrievedinpatientswithintrahepaticcholangiocarcinomaacollaborativekoreajapanstudy
AT takaharatakeshi shouldlymphnodesberetrievedinpatientswithintrahepaticcholangiocarcinomaacollaborativekoreajapanstudy
AT shiozakishigehiro shouldlymphnodesberetrievedinpatientswithintrahepaticcholangiocarcinomaacollaborativekoreajapanstudy
AT rohyounghoon shouldlymphnodesberetrievedinpatientswithintrahepaticcholangiocarcinomaacollaborativekoreajapanstudy
AT yuheechul shouldlymphnodesberetrievedinpatientswithintrahepaticcholangiocarcinomaacollaborativekoreajapanstudy
AT fukumototakumi shouldlymphnodesberetrievedinpatientswithintrahepaticcholangiocarcinomaacollaborativekoreajapanstudy
AT matsuyamaryusei shouldlymphnodesberetrievedinpatientswithintrahepaticcholangiocarcinomaacollaborativekoreajapanstudy
AT naokiuyama shouldlymphnodesberetrievedinpatientswithintrahepaticcholangiocarcinomaacollaborativekoreajapanstudy
AT hashidakazuki shouldlymphnodesberetrievedinpatientswithintrahepaticcholangiocarcinomaacollaborativekoreajapanstudy
AT seohyungil shouldlymphnodesberetrievedinpatientswithintrahepaticcholangiocarcinomaacollaborativekoreajapanstudy
AT okabayashitakehiro shouldlymphnodesberetrievedinpatientswithintrahepaticcholangiocarcinomaacollaborativekoreajapanstudy
AT kitajimatomoo shouldlymphnodesberetrievedinpatientswithintrahepaticcholangiocarcinomaacollaborativekoreajapanstudy
AT satoisohei shouldlymphnodesberetrievedinpatientswithintrahepaticcholangiocarcinomaacollaborativekoreajapanstudy
AT naganohiroaki shouldlymphnodesberetrievedinpatientswithintrahepaticcholangiocarcinomaacollaborativekoreajapanstudy
AT kimhongbeom shouldlymphnodesberetrievedinpatientswithintrahepaticcholangiocarcinomaacollaborativekoreajapanstudy
AT tairakaoru shouldlymphnodesberetrievedinpatientswithintrahepaticcholangiocarcinomaacollaborativekoreajapanstudy
AT kuboshoji shouldlymphnodesberetrievedinpatientswithintrahepaticcholangiocarcinomaacollaborativekoreajapanstudy
AT choidongwook shouldlymphnodesberetrievedinpatientswithintrahepaticcholangiocarcinomaacollaborativekoreajapanstudy